Literature DB >> 7074128

Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.

K Y Hostetler, L B Hall.   

Abstract

Accumulation of aminoglycoside antibiotics and phospholipids in lysosomes is a prominent feature of aminoglycoside nephrotoxicity, suggesting the possibility that these agents may inhibit the activity of lysosomal phospholipases. We examined the effect of four aminoglycoside antibiotics, amikacin, dibekacin gentamicin and tobramycin, on the hydrolysis of [3H]dioleoylphosphatidylcholine by a lysosomal protein fraction obtained from rat liver which contains phospholipase A and C. Phospholipase A was inhibited strongly by these agents. Phospholipase C was also inhibited, especially by amikacin and tobramycin. These results suggest that the accumulation of phospholipids in the kidney cortex in aminoglycoside nephrotoxicity may be due to inhibition of lysosomal phospholipase action.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074128     DOI: 10.1016/0005-2760(82)90136-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Induction and inhibition of pinocytosis by aminoglycoside antibiotics.

Authors:  P Johansson; J O Josefsson; L Nässberger
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

2.  Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.

Authors:  M B Carlier; G Laurent; P J Claes; H J Vanderhaeghe; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

3.  Pig kidney (LLC-PK1) cell membrane fluidity during exposure to gentamicin or tobramycin.

Authors:  S J Kohlhepp; L Hou; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 4.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.